Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilda Padalino

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Wellcome Open Research|November 17, 2020
Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activitiesGilda Padalino, Iain W Chalmers, Andrea Brancale, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 13, 2019
Erratum to 'Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni' [IJP Drugs Drug Resist. 8 (2018) 559-570]Gilda Padalino, Salvatore Ferla, Andrea Brancale, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2018
Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoniGilda Padalino, Salvatore Ferla, Andrea Brancale, et al.
Wellcome Open Research|August 25, 2022
Identification of anti-schistosomal, anthelmintic and anti-parasitic compounds curated and text-mined from the scientific literatureAvril Coghlan, Gilda Padalino, Noel M O'Boyle, et al.
Trends in Parasitology|January 2, 2017
(Epi)genetic Inheritance in Schistosoma mansoni: A Systems ApproachCéline Cosseau, Olaf Wolkenhauer, Gilda Padalino, et al.
Pharmaceutics|May 27, 2023
Using ChEMBL to Complement Schistosome Drug DiscoveryGilda Padalino, Avril Coghlan, Giampaolo Pagliuca, et al.
Microbiologyopen|December 12, 2024
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their BiofilmsGilda Padalino, Katrina Duggan, Luis A J Mur, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial ActivityMukul Rawat, Gilda Padalino, Tomas Yeo, et al.
Plos Pathogens|February 3, 2025
Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activityMukul Rawat, Gilda Padalino, Edem Adika, et al.
Science (New York, N.Y.)|September 25, 2020
Large-scale RNAi screening uncovers therapeutic targets in the parasite <i>Schistosoma mansoni</i>Jipeng Wang, Carlos Paz, Gilda Padalino, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Wellcome Open Research|November 17, 2020
Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activitiesGilda Padalino, Iain W Chalmers, Andrea Brancale, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 13, 2019
Erratum to 'Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni' [IJP Drugs Drug Resist. 8 (2018) 559-570]Gilda Padalino, Salvatore Ferla, Andrea Brancale, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2018
Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoniGilda Padalino, Salvatore Ferla, Andrea Brancale, et al.
Wellcome Open Research|August 25, 2022
Identification of anti-schistosomal, anthelmintic and anti-parasitic compounds curated and text-mined from the scientific literatureAvril Coghlan, Gilda Padalino, Noel M O'Boyle, et al.
Trends in Parasitology|January 2, 2017
(Epi)genetic Inheritance in Schistosoma mansoni: A Systems ApproachCéline Cosseau, Olaf Wolkenhauer, Gilda Padalino, et al.
Pharmaceutics|May 27, 2023
Using ChEMBL to Complement Schistosome Drug DiscoveryGilda Padalino, Avril Coghlan, Giampaolo Pagliuca, et al.
Microbiologyopen|December 12, 2024
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their BiofilmsGilda Padalino, Katrina Duggan, Luis A J Mur, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial ActivityMukul Rawat, Gilda Padalino, Tomas Yeo, et al.
Plos Pathogens|February 3, 2025
Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activityMukul Rawat, Gilda Padalino, Edem Adika, et al.
Science (New York, N.Y.)|September 25, 2020
Large-scale RNAi screening uncovers therapeutic targets in the parasite <i>Schistosoma mansoni</i>Jipeng Wang, Carlos Paz, Gilda Padalino, et al.
Pageof 3